Liraglutide in the management of type 2 diabetes
Estela Wajcberg, Amatur AmarahPremier Nephrology and Hypertension, Internal Medicine Department, Trinitas Regional Medical Center, Elizabeth, New Jersey, USAAbstract: The pathophysiology of type 2 diabetes has been attributed to the classic triad of decreased insulin secretion, increased insulin res...
Saved in:
Main Authors: | Estela Wajcberg (Author), Amatur Amarah (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2010-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Combination therapies in the management of type 2 diabetes: the use of insulin degludec/liraglutide
by: Minze MG, et al.
Published: (2016) -
Liraglutide Therapy for Type 2 Diabetes: Overcoming Unmet Needs
by: Åke Sjöholm
Published: (2010) -
Off-Label Use of Liraglutide in the Management of a Pediatric Patient with Type 2 Diabetes Mellitus
by: Sara J. Micale, et al.
Published: (2013) -
Liraglutide exerts an anti-inflammatory action in obese patients with type 2 diabetes
by: Savchenko Liudmyla G., et al.
Published: (2019) -
Selecting GLP-1 agonists in the management of type 2 diabetes: differential pharmacology and therapeutic benefits of liraglutide and exenatide
by: Jonathan Pinkney, et al.
Published: (2010)